Ethical examination of clinical trials. Necessity and absence of necessity

Not all studies involving people require a prospective examination…

A new drug for the treatment of migraine may appear in Europe

The Expert Council of the European Medicines Agency recommended…

The drug for the treatment of autoimmune skin disease received the status of "breakthrough therapy"

The US Food and Drug Administration (FDA) assigned the status…

Why do all pharma industry stakeholders must collaborate and encourage patients to share their personal data?

Currently there is an increasing concern regarding personal data…

Why people aren’t interested in being part of clinical trials?

According to a recent national survey of consumers and physicians…

Cancer cells hide mutations in the years before the development of a tumor

Genetic changes in cancer bone cells can appear in the years…

X7 Research will take part in the annual BIOTECHMED forum 2018

Dear colleagues, our company X7 Research will take part in the…

FDA warning letter to the Indian drug manufacturer Goran Pharma

FDA has published a warning letter to the Indian drug manufacturer…

FDA statement on probiotics

On the 16th of September there has been published a new statement…

III and IV Phases of clinical trials

III Phase of clinical trials If the drug is effective and…